or Try an Advanced Search...

    Technical Analysis for VXRT - Vaxart, Inc.

    Grade Last Price % Change Price Change
    F 0.69 3.19% 0.02
    VXRT closed up 3.19 percent on Monday, July 1, 2024, on 37 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical VXRT trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Hammer Candlestick Bullish 3.19%
    Wide Bands Range Expansion 3.19%
    Wide Bands Range Expansion 3.39%
    Down 3 Days in a Row Weakness 3.39%
    Calm After Storm Range Contraction 1.89%
    NR7 Range Contraction 1.89%
    Wide Bands Range Expansion 1.89%
    Older End-of-Day Signals for VXRT ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 4 hours ago
    60 Minute Opening Range Breakout about 5 hours ago
    Hammer Candlestick Entry about 5 hours ago
    Rose Above Previous Day's High about 5 hours ago
    Up 2% about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VXRT Chart by TradingView
    Basic chart:

    Profile

    Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Human Papilloma Virus Human Papillomavirus Infection Vaccine Preventable Diseases

    Is VXRT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding
    Jun 22 While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
    Jun 21 $1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
    Jun 18 Vaxart anticipates funds to extend its cash runway into 2026
    Jun 17 Vaxart Provides Business Update
    Jun 14 Biggest stock movers today: ADBE, MSM, RH, and more
    Jun 14 Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
    Jun 14 Vaxart to raise $40M via stock offering
    Jun 13 Vaxart Announces $40 Million Underwritten Offering of Common Stock
    Jun 13 Vaxart soars after hours on $453M award to evaluate COVID-19 oral pill vaccine candidate
    See more VXRT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.54
    52 Week Low 0.52
    Average Volume 4,451,510
    200-Day Moving Average 0.85
    50-Day Moving Average 0.77
    20-Day Moving Average 0.72
    10-Day Moving Average 0.68
    Average True Range 0.07
    RSI (14) 44.75
    ADX 17.85
    +DI 17.61
    -DI 24.17
    Chandelier Exit (Long, 3 ATRs) 0.64
    Chandelier Exit (Short, 3 ATRs) 0.74
    Upper Bollinger Bands 0.87
    Lower Bollinger Band 0.57
    Percent B (%b) 0.4
    BandWidth 41.61
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram 0.0019
    Fundamentals Value
    Market Cap 105.64 Million
    Num Shares 153 Million
    EPS -0.63
    Price-to-Earnings (P/E) Ratio -1.09
    Price-to-Sales 43.93
    Price-to-Book 2.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.75
    Resistance 3 (R3) 0.75 0.72 0.74
    Resistance 2 (R2) 0.72 0.71 0.72 0.74
    Resistance 1 (R1) 0.71 0.69 0.71 0.71 0.73
    Pivot Point 0.68 0.68 0.68 0.68 0.68
    Support 1 (S1) 0.66 0.66 0.67 0.67 0.64
    Support 2 (S2) 0.64 0.65 0.64 0.64
    Support 3 (S3) 0.62 0.64 0.64
    Support 4 (S4) 0.62